Table 1. Patient and lesion histopathology characteristics.
| Characteristic | N | (%) |
|---|---|---|
| Patient age | ||
| <40 years | 149 | 23.8 |
| 40-50 years | 230 | 36.7 |
| 50-74 years | 238 | 37.9 |
| >74 years | 10 | 1.6 |
| BI-RADS assessment score | ||
| BI-RADS 2 | 21 | 3.3 |
| BI-RADS 3 | 57 | 9.1 |
| BI-RADS 4 | 343 | 54.7 |
| BI-RADS 5 | 116 | 18.5 |
| BI-RADS 6 | 90 | 14.4 |
| Lesion enhancement type | ||
| Mass | 407 | 64.9 |
| Non–mass | 220 | 35.1 |
| Benign lesions | 382 | 61 |
| Benign breast parenchyma | 72 | 18.8 |
| Fibrocystic | 70 | 18.3 |
| Fibroadenoma | 70 | 18.3 |
| Atypical Ductal Hyperplasia | 34 | 8.9 |
| Atypical Lobular Hyperplasia | 16 | 4.2 |
| Fibrosis | 20 | 5.2 |
| Duct Papilloma | 19 | 5.0 |
| Sclerosing Adenosis | 19 | 5.0 |
| Columnar cell changes | 18 | 4.7 |
| In-situ Lobular Carcinoma | 7 | 1.8 |
| others | 37 | 9.8 |
| Malignant lesions | 245 | 39 |
| Invasive Ductal Carcinoma | 136 | 55.5 |
| In-situ Ductal Carcinoma | 80 | 32.7 |
| In-situ papillary Carcinoma | 3 | 1.2 |
| Invasive Lobular Carcinoma | 21 | 8.6 |
| others | 5 | 2.0 |